Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551152-24-000031
Filing Date
2024-08-07
Accepted
2024-08-07 15:00:51
Documents
79
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abbv-20240630.htm   iXBRL 10-Q 2349062
2 EX-31.1 abbv-20240630xex311.htm EX-31.1 9018
3 EX-31.2 abbv-20240630xex312.htm EX-31.2 9264
4 EX-32.1 abbv-20240630xex321.htm EX-32.1 4699
5 EX-32.2 abbv-20240630xex322.htm EX-32.2 4748
11 abbv-20240630_g1.jpg GRAPHIC 15145
12 abbv-20240630_g2.gif GRAPHIC 748
  Complete submission text file 0001551152-24-000031.txt   11574823

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20240630.xsd EX-101.SCH 58067
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20240630_cal.xml EX-101.CAL 100614
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20240630_def.xml EX-101.DEF 366877
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20240630_lab.xml EX-101.LAB 764787
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20240630_pre.xml EX-101.PRE 532035
82 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20240630_htm.xml XML 2353558
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35565 | Film No.: 241183091
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)